• EADV congress Berlin 11-14 October 2023
    At the EADV (European Academy of Dermatology and Venereology) congress, Charlotte van Riel, physician-researcher in the department of dermatology at Radboudumc and affiliated with the BeNeBio study, presented a poster with the baseline data of participants in the BeNeBio study.
  • Patient inclusion is closed
    On 14 September 2023, the last patient was included in the BeNeBio study. With this, we have achieved our goal of including 244 patients!We are very happy about this. To all centres and patients participating in the BeNeBio study: thank you very much!
  • First BeNeBio publication
    Recently, a manuscript of the BeNeBio study protocol was published in BMC Trials. You might access the paper here: Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study. Lisa Schots also presented the study protocol in a poster … Read more
  • BeNeBio study – 2021
    On behalf of the BeNeBio study team we wish everyone a happy and healthy 2021. We will look forward to further collaborations with all involved parties, because ‘together we make BeNeBio work’!
  • Start first Belgian hospitals
    Currently, the first Belgian hospitals have been started with the BeNeBio study. This means that also in Belgium the first patients have been included for participation in the study!